The Cooper Companies, Inc. $COO Shares Sold by Bank of America Corp DE

Key Points

• Bank of America reduced its Cooper Companies stake by 1.5% in the first quarter, selling 22,431 shares and retaining 1.44 million shares valued at approximately $102.8 million. Institutional investors and hedge funds collectively own 24.39% of COO.
• Cooper Companies reported quarterly earnings of $1.21 per share, beating estimates of $1.10, while revenue rose 7.9% year over year to $1.08 billion. The company issued fiscal 2026 EPS guidance of $4.58–$4.66.
• Analyst sentiment remains mixed, with MarketBeat reporting an overall “Hold” rating and a consensus price target of $81.36, compared with the stock’s stated opening price of $74.23.

Bank of America Corp DE trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,438,113 shares of the medical device company's stock after selling 22,431 shares during the period. Bank of America Corp DE owned 0.74% of Cooper Companies worth $102,825,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in COO. Root Financial Partners LLC raised its holdings in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock valued at $26,000 after buying an additional 162 shares during the period. SJS Investment Consulting Inc. boosted its holdings in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after acquiring an additional 187 shares during the period. CYBER HORNET ETFs LLC acquired a new stake in Cooper Companies in the second quarter valued at approximately $36,000. MUFG Securities EMEA plc acquired a new stake in Cooper Companies in the second quarter valued at approximately $42,000. Finally, IFP Advisors Inc raised its stake in shares of Cooper Companies by 2,647.8% during the third quarter. IFP Advisors Inc now owns 632 shares of the medical device company's stock valued at $43,000 after purchasing an additional 609 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Shares of COO stock opened at $74.23 on Friday. The stock has a market capitalization of $14.48 billion, a price-to-earnings ratio of 62.91, a PEG ratio of 1.92 and a beta of 0.83. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company's 50-day simple moving average is $69.64 and its 200-day simple moving average is $71.51. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the company earned $0.96 earnings per share. Cooper Companies's quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $95.00 to $85.00 and set a "buy" rating for the company in a report on Friday, June 5th. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a research report on Sunday, June 21st. JPMorgan Chase & Co. lowered their target price on Cooper Companies from $80.00 to $71.00 and set a "neutral" rating for the company in a research note on Friday, June 5th. Citigroup reaffirmed a "neutral" rating and set a $76.00 target price (up from $69.00) on shares of Cooper Companies in a research report on Wednesday, July 8th. Finally, Piper Sandler set a $86.00 price target on Cooper Companies and gave the stock an "overweight" rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat, Cooper Companies has an average rating of "Hold" and a consensus price target of $81.36.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source